What is Oxymed?
Oxymed specializes in providing essential durable medical equipment, with a particular focus on respiratory care solutions. Their product portfolio includes advanced CPAP and BiPAP machines, masks, and portable oxygen concentrators. The company's flagship offering, the X-PLOR Portable Oxygen Concentrator, is engineered for individuals who require consistent oxygen support while maintaining an active lifestyle. OxyMed is committed to upholding stringent quality assurance standards, delivering exceptional customer service, and offering comprehensive support, including guidance on insurance coverage. The company primarily serves individuals managing sleep apnea and other respiratory conditions, ensuring they have access to the necessary equipment and training for effective treatment.
How much funding has Oxymed raised?
Oxymed has raised a total of $318K across 2 funding rounds:
Debt
$150K
Debt
$168K
Debt (2020): $150K with participation from PPP
Debt (2021): $168K led by PPP
What's next for Oxymed?
With its recent large-scale late-stage funding and a major strategic investment, Oxymed is poised for accelerated growth. The capital infusion is anticipated to bolster its research and development efforts, potentially leading to new product innovations in respiratory technology. Furthermore, the financing will likely support an expansion of its market reach, both domestically and internationally, and enhance its operational capabilities to meet increasing demand. The company's strategic focus on quality and customer support, combined with its specialized product offerings, positions it favorably for continued success in the competitive durable medical equipment market.
See full Oxymed company page
